Terms: = Head and neck cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Treatment
71 results:
1. THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF-1/VEGF signaling pathway.
Zhou X; Xia Q; Chen M; Zhang X; Huang M; Zheng X; Wang S; Wu B; Du Z
Cell Biol Int; 2024 Mar; 48(3):311-324. PubMed ID: 38233982
[TBL] [Abstract] [Full Text] [Related]
2. Elective neck Dissection for cT1-4 N0M0 head and neck Verrucous Carcinoma.
Patel AM; Vedula S; Haleem A; Choudhry HS; Tseng CC; Park RCW
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1187-1199. PubMed ID: 37278222
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.
Erul E; Guven DC; Ozbay Y; Altunbulak AY; Kahvecioglu A; Ercan F; Yesil MF; Ucdal MT; Cengiz M; Yazici G; Kuscu O; Suslu N; Gullu I; Onur MR; Aksoy S
Biomark Med; 2023 Jan; 17(2):87-99. PubMed ID: 37042459
[TBL] [Abstract] [Full Text] [Related]
4. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
6. Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma.
Xu K; Wu H; Zhou C; Bao Y; Yu M; Zhang L; Li X
Int J Clin Pharm; 2023 Jun; 45(3):641-649. PubMed ID: 36800145
[TBL] [Abstract] [Full Text] [Related]
7. Causes of Middle Ear Aural Polyps in Adult Patients from Kut and Diwaniyah Cities in Iraq.
Ali OA; Ali MSA; Aljelihawi FMM
Int Tinnitus J; 2022 Dec; 26(2):127-132. PubMed ID: 36724361
[TBL] [Abstract] [Full Text] [Related]
8. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
[No Abstract] [Full Text] [Related]
9. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
[TBL] [Abstract] [Full Text] [Related]
10. Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis.
Chiesa-Estomba CM; Urazan JD; Cammaroto G; Mannelli G; Molteni G; Dallari V; Lechien JR; Mayo-Yanez M; González-García JÁ; Sistiaga-Suarez JA; Tucciarone M; Ayad T; Meccariello G
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):869-876. PubMed ID: 36102986
[TBL] [Abstract] [Full Text] [Related]
11. [Survival rate and quality of life of human papillomaviruse-negative patients with advanced oropharyngeal cancer receiving different treatments].
Li J; Guo Y; Cui W; Sun Y; Yang D; Liu L; Wu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1230-1236. PubMed ID: 36073223
[TBL] [Abstract] [Full Text] [Related]
12. Stage-Specific Survival in Young Patients With Oral Tongue Squamous Cell Carcinoma.
Bommakanti KK; Abiri A; Han AY; Goshtasbi K; Kuan EC; St John MA
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):398-406. PubMed ID: 35700039
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
Kiong KL; Moreno A; Vu CN; Zheng G; Rosenthal DI; Weber RS; Lewis CM
Oral Oncol; 2022 Jul; 130():105906. PubMed ID: 35594776
[TBL] [Abstract] [Full Text] [Related]
14. Oral cancer patients achieve comparable survival at high safety-net burden hospitals.
Lam CM; Qureshi MM; Patel PN; Park JJ; Dang RR; Rubin SJ; Salama AR; Truong MT
Am J Otolaryngol; 2022; 43(3):103438. PubMed ID: 35489110
[TBL] [Abstract] [Full Text] [Related]
15. N
Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
[TBL] [Abstract] [Full Text] [Related]
16. Trends in HPV Testing for Patients With Sinonasal Squamous Cell Carcinoma: A National Analysis.
Tseng CC; Gao J; Barinsky GL; Fang CH; Hsueh WD; Grube JG; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2022 Sep; 167(3):501-508. PubMed ID: 34962837
[TBL] [Abstract] [Full Text] [Related]
17. A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
Berg M; Adnan A; Högmo A; Sjödin H; Gebre-Medhin M; Laurell G; Reizenstein J; Farnebo L; Norberg LS; Notstam I; Holmberg E; Cange HH; Hammerlid E;
Head Neck; 2021 Dec; 43(12):3843-3856. PubMed ID: 34558771
[TBL] [Abstract] [Full Text] [Related]
18. Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid cancers (ROCKIT): A Meta-Analysis of 13 Studies.
Tchelebi LT; Batchelder E; Wang M; Lehrer EJ; Drabick JJ; Sharma N; Machtay M; Trifiletti DM; Zaorsky NG
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34350378
[TBL] [Abstract] [Full Text] [Related]
19. Pre-Operative Antithyroid Antibodies in Differentiated Thyroid cancer.
Noel JE; Thatipamala P; Hung KS; Chen J; Shi RZ; Orloff LA
Endocr Pract; 2021 Nov; 27(11):1114-1118. PubMed ID: 34217894
[TBL] [Abstract] [Full Text] [Related]
20. It Takes Two to tango: Patients' and Providers' Perspectives in Tobacco Cessation and head/neck cancer.
Khodadadi AB; Carroll W; Lee EL; Hansen B; Scarinci IC
Oncologist; 2021 Sep; 26(9):761-770. PubMed ID: 34105215
[TBL] [Abstract] [Full Text] [Related]
[Next]
